How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Hmd Biomedical, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
10 clearance records and 0 recall records in the covered releases, across 1 source company names and 2 product codes. Dated history runs from Aug 4, 2003 to Aug 29, 2022.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| NBW · System, Test, Blood Glucose, Over The Counter | 7 | 0 |
| LFR · Glucose Dehydrogenase, Glucose | 3 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| GlucoLeader Enhance 2 Blood Glucose Monitoring SystemK212248 · NBW | Hmd Biomedical, Inc. | 510(k) | Aug 29, 2022FDA decision date |
| GlucoLeader Enhance Blood Glucose Monitoring SystemK182428 · NBW | Hmd Biomedical, Inc. | 510(k) | May 8, 2019FDA decision date |
| Goodlife AC-300 Blood Glucose Monitoring System, Goodlife AC-301 Blood Glucose Monitoring System, Goodlife AC-302 Blood Glucose Monitoring System…K140150 · NBW | Hmd Biomedical, Inc. | 510(k) | May 14, 2015FDA decision date |
| FIA Blood Glucose Monitoring System (G2)K131173 · NBW | Hmd Biomedical, Inc. | 510(k) | Sep 18, 2014FDA decision date |
| GOODLIFE CS-200 (SINGLE PATIENT USE), CS-200 PROFESSIONAL (MULTIPLE PATIENT USE) BLOOD GLUCOSE MONITORING SYSTEMSK121433 · LFR | Hmd Biomedical, Inc. | 510(k) | Feb 14, 2013FDA decision date |
| PRECICHEK NS-101 POCT PROFESSIONAL BLOOD GLUCOSE MONITORING SYSTEMK113314 · LFR | Hmd Biomedical, Inc. | 510(k) | Nov 9, 2012FDA decision date |
| TEST, BLOOD GLUCOSE SYSTEMK120064 · NBW | Hmd Biomedical, Inc. | 510(k) | Sep 5, 2012FDA decision date |
| GL GOODLIFE SERIES BLOOD GLUCOSE MONITORING SYSMTEMK113307 · LFR | Hmd Biomedical, Inc. | 510(k) | Jul 27, 2012FDA decision date |
| GLUCOLEADER ENHANCE SELF-MONITORING OF BLOOD GLUCOSE SYSTEMK032985 · NBW | Hmd Biomedical, Inc. | 510(k) | Oct 21, 2003FDA decision date |
| GLUCOLEADER VALUEK023279 · NBW | Hmd Biomedical, Inc. | 510(k) | Aug 4, 2003FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.